FWBI - First Wave BioPharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

First Wave BioPharma's activity chart (see below) currently has 13 price targets and 24 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 30.33 days.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 25-Mar-2024. First documented stock forecast 17-Oct-2018.

Best performing analysts who are covering FWBI - First Wave BioPharma:

Jonathan Aschoff Yi Chen Jason Mccarthy Leland Gershell

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 25-Mar-2024

2 years 7 months 7 days ago
(25-Mar-2024)

0/4 (0%)

$251.6 (232.10%)

Buy Since 01-Apr-2021

2 years 9 months 29 days ago
(03-Jan-2024)

0/3 (0%)

$2070.63 (482.25%)

Hold Since 10-Dec-2021

$126000.25

4 years 10 months 22 days ago
(10-Dec-2021)

0/3 (0%)

$96507.95 (327.23%)

Buy Since 17-Oct-2018

$336000.66

$335997.69 (11275090.00%)

$252000.5

7 years 8 months 6 days ago
(26-Feb-2019)

0/2 (0%)

$247469.2 (279.53%)

Show more analysts

Please expand the browser size to see the chart

What is FWBI (First Wave BioPharma) average time for price targets to be met?

On average it took 30 days for the stock forecasts to be reached, with an average price target met ratio of 33.33%.

Which analyst most recently updated their price target on FWBI (First Wave BioPharma)?

Yi Chen

Which analyst has the current lower performing score on FWBI (First Wave BioPharma) with a proven track record?

LELAND GERSHELL

Which analyst has the most public recommendations on FWBI (First Wave BioPharma)?

Yi Chen works at HC WAINWRIGHT and has 17 price targets and 10 ratings on FWBI

Which analyst is the currently most bullish on FWBI (First Wave BioPharma)?

Leland Gershell with the highest potential upside of $335997.69

Which analyst is the currently most reserved on FWBI (First Wave BioPharma)?

Jonathan Aschoff with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?